Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02951884Phase 4Terminated
Phase 4, randomised, single-blind trial of bupivacaine in tibial plateau fracture (3 arms), sponsored by Loyola University Chicago. Primary endpoint: Numerical Rating Scale Pain Scores at 24 hours. Started Jun 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02951884.